PharmaCielo Ltd.
PCLO.V
TSX
| 06/30/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 50.03% | 5.83% | 29.47% | 29.47% | 31.79% |
| Total Depreciation and Amortization | -94.23% | -107.69% | -86.22% | -6.48% | -71.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.43% | 62.96% | 90.25% | 64.56% | -43.29% |
| Change in Net Operating Assets | 934.46% | -103.48% | -147.39% | -147.39% | 92.85% |
| Cash from Operations | 445.85% | 40.51% | 62.53% | 62.53% | 63.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | -- | -82.30% |
| Cash from Investing | -- | -100.00% | -100.00% | -100.00% | -81.32% |
| Total Debt Issued | -85.43% | -100.00% | -55.33% | -42.80% | -75.39% |
| Total Debt Repaid | -492.20% | 8.46% | -18.95% | -18.95% | 20.16% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -552.70% | -31.66% | -60.57% | -60.57% | -59.09% |
| Foreign Exchange rate Adjustments | 54.55% | 16.67% | 10.81% | 10.81% | -72.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.77% | 82.67% | 62.05% | 62.05% | -59.97% |